-
-
-
-
-
-
News
-
-
Contact UsThe company focuses on the research, development, production, and sales of chemical raw materials and their formulations. All products have passed national GMP certification, and core products have successively passed official pharmaceutical regulatory certifications from multiple countries, including the EU EDQM, US FDA, Japanese PMDA, and South Korean MFDS. Following its successful listing on the Shenzhen Stock Exchange's ChiNext board on April 4, 2023, Keyuan Pharmaceutical has entered a phase of rapid development driven by both digital intelligence and capital, with its business spanning dozens of countries and regions worldwide.
Company Establishment Time
Stock Code
Professional and technical personnel
Products are sold to countries and regions worldwide.
Service Platform
Active Pharmaceutical Ingredient (API) CMO/CDMO Business Formulated Pharmaceutical Products (CMO/CDMO Business) Medical Aesthetic Materials (CMO/CDMO Business) Specialized Pilot Production Platform
Technology Platform
Nitrification technology Hydrogenation technology Sulfonation technology Fluorination technology Chiral catalysis technology Enzyme catalysis technology
Shandong Keyuan Pharmaceutical Co.,Ltd.
Shandong Keyuan Pharmaceutical Co.,Ltd. is a domestic enterprise in the chemical raw material medicine segment, with products covering key disease areas such as hypoglycemic, anesthetic, cardiovascular and mental diseases.
The company focuses on the research, development, production and sales of chemical raw materials and their preparations. Core products have successively passed official drug administration certifications from multiple countries, including EU CEP, US FDA, Japan PMDA, and Korea MFDS.
After successfully listing on April 4, 2023, Keyuan Pharmaceutical has entered a stage of rapid development driven by both digital intelligence and capital, with business covering dozens of countries and regions around the world.
Corporate Honors
With its cutting-edge technological innovation, technological research and development capabilities, and hard-core quality control capabilities, Keyuan Pharmaceutical has won numerous awards.
High-tech enterprise
Jinan Green Factory
Top 50 Sci-Tech Innovative Private Enterprises in Jinan
Jinan City New and Old Kinetic Energy Conversion Public Training Base
Product Center
The company has been deeply engaged in chemical raw materials for more than 20 years, continuously strengthening its core advantages in the fields of hypoglycemic and cardiovascular diseases, actively expanding new business areas such as cosmetic raw materials, high-end pharmaceutical excipients, and functional food additives, and building an industrial ecosystem of "raw materials + multi-field synergy".
Beijing R&D Base: Nuokangda
Beijing Nuokanda Pharmaceutical Technology Co., Ltd. is an innovation-driven, full-chain pharmaceutical CRO enterprise specializing in formulation technology platforms tailored to clinical needs. It is recognized as a National High-Tech Enterprise, a National Intellectual Property Demonstration Enterprise, and hosts a Postdoctoral Research Station. For six consecutive years, the company has been ranked among the top 20 "China's Top 20 Pharmaceutical R&D Companies" by the All-China Federation of Industry and Commerce, and it has undertaken or participated in two key national major new drug development projects under the 13th Five-Year Plan. In 2023, Keyuan Pharmaceutical acquired a 12% stake in Nuokanda, making it the company's second-largest shareholder. Today, Nuokanda has become Keyuan Pharmaceutical's Beijing-based R&D hub.
Focus on Keyuan Dynamics
Listen to Keyuan's voice, perceive the pulse of innovation, focus on the forefront of the industry, and work together to create a new chapter of development
On June 28–29, the third Global Outbound Summit, hosted by the Wu Xiaobo Channel and the Chinese Business Globalization Industry Alliance, was grandly held at Resorts World Sentosa in Singapore. Centered around the theme “Born Global—Going Global for Growth,” the summit aligned with the prevailing trend of profound restructuring in global supply chains and the accelerated globalization of China’s real economy. It brought together more than 1,400 entrepreneurs from home and abroad, leading economists, representatives from top-tier investment firms, and experts from industry think tanks, creating a high‑level platform for dialogue, resource matchmaking, and knowledge sharing to support Chinese companies’ international expansion.
2026-06-29
To thoroughly implement the latest requirements of the Criminal Law Amendment (No. 12), effectively strengthen all employees’ awareness of integrity and compliance, prevent and mitigate internal risks of official misconduct, and safeguard the company’s high-quality development, on May 20, Keyuan Group organized a company-wide training session on corruption prevention and compliance. Led by the Human Resources Center and the Audit Center, the event adopted a hybrid online–offline format to ensure full coverage, mandatory participation, and comprehensive learning for all employees.
2026-05-20
Contact Keyuan
For any questions or cooperation intentions, please feel free to contact us.
Our team is always ready to provide you with professional support and solutions!
Address: No. 26, Keyuan Street, Shanghe County, Jinan City, Shandong Province
Free Service Hotline